Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 06-2005 | 12-2004 | 06-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,300 | 37,570 | 29,380 | 54,110 | 41,470 |
| Marketable Securities | 0 | 0 | 2,090 | 2,930 | 1,750 |
| Receivables | 14,200 | 28,850 | 38,050 | 30,120 | 27,900 |
| Inventories | 3,600 | 4,630 | 2,930 | 2,480 | 2,350 |
| Other current assets | 400 | 1,570 | 20 | 10 | 10 |
| TOTAL | $52,500 | $72,620 | $72,470 | $89,650 | $73,480 |
| Non-Current Assets | |||||
| Investments And Advances | 200 | 31,110 | 38,510 | 38,990 | 41,790 |
| Other Non-Current Assets | 97,100 | 185,910 | 175,340 | 171,240 | 169,700 |
| TOTAL | $97,300 | $217,020 | $213,850 | $210,230 | $211,490 |
| Total Assets | $186,900 | $357,550 | $364,180 | $372,860 | $361,030 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,300 | 0 | 18,720 | 0 | 0 |
| Accounts payable and accrued liabilities | 21,000 | 32,230 | 46,910 | 37,300 | 70,170 |
| Other current liabilities | 7,700 | 20,100 | 27,380 | 130,280 | 0 |
| TOTAL | $43,000 | $75,470 | $93,020 | $167,590 | $70,170 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,200 | 91,450 | 127,370 | 0 | 0 |
| Other Non-Current Liabilities | 68,900 | 126,560 | 21,400 | 58,120 | 131,640 |
| TOTAL | $112,000 | $222,390 | $149,240 | $65,650 | $136,900 |
| Total Liabilities | $155,000 | $297,890 | $242,280 | $233,250 | $207,080 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,376 | N/A | N/A | N/A | N/A |
| Common Shares | 76,600 | 118,860 | 121,550 | 114,700 | 112,550 |
| Retained earnings | -427,100 | -724,370 | -632,550 | -572,370 | -544,970 |
| Other shareholders' equity | 36,800 | 64,700 | 17,910 | 16,910 | 16,690 |
| TOTAL | $31,900 | $59,650 | $121,900 | $139,610 | $153,950 |
| Total Liabilities And Equity | $186,900 | $357,540 | $364,180 | $372,860 | $361,030 |